Mats Eriksson - Concepedia

Author

Mats Eriksson

Also Known As

Derek L Connolly, Eriksson M., Eriksson, M, M Eriksson, M. ERIKSSON, M. Eriksson, MATS ERIKSSON, Mats A. L. Eriksson, Mats A.L. Eriksson, Mats Eriksson

188

Publications

10.5K

Citations

H-Index

108

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Umeå University Sahlgrenska University Hospital University of Gothenburg

About

Mats Eriksson is an author at Karolinska Institutet specializing in medicine, metabolic syndrome, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	30	2.5K
2	Health Sciences	13	14	1.6K
3	Natural Sciences	6	6	252
4	Engineering	2	2	55
5	Public Health	2	2	120

Mats Eriksson

101

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Effects of Torcetrapib in Patients at High Risk for Coronary Events Philip J. Barter, Mark J. Caulfield, Mats Eriksson, New England Journal of Medicine	2007	3.1K
The Circulating Metabolic Regulator FGF21 Is Induced by Prolonged Fasting and PPARα Activation in Man Cecilia Gälman, Tomas Lundåsen, Alexei Kharitonenkov, Cell Metabolism Metabolic SyndromeGrowth HormoneMetabolic DisorderPhysiologyProlonged Fasting	2008	492
The Swedish CArdioPulmonary BioImage Study: objectives and design Göran Bergström, G Berglund, Anders Blomberg, Journal of Internal Medicine	2015	428
Dynamics of human adipose lipid turnover in health and metabolic disease Peter Arner, Samuel Bernard, Mehran Salehpour, Nature ObesityMetabolic SyndromeBody CompositionMetabolic DisorderLipid Metabolism	2011	392
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population Göran Bergström, Margaretha Persson, Martin Adiels, Circulation	2021	381
Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145) Frederick J. Raal, Robert P. Giugliano, Marc S. Sabatine, Journal of the American College of Cardiology InflammationAllergyImmunologyHyperlipidemiaVascular Biology	2014	357
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study Kausik K. Ray, Inaam Haq, Aikaterini Bilitou, The Lancet Regional Health - Europe	2023	273
Stimulation of Fecal Steroid Excretion After Infusion of Recombinant Proapolipoprotein A-I Mats Eriksson, Lars A. Carlson, Tatu A. Miettinen, Circulation	1999	232
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver Paolo Parini, Matthew A. Davis, Aaron T. Lada, Circulation	2004	217
Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans Lena Persson, Guoqing Cao, Lars Ståhle, Arteriosclerosis Thrombosis and Vascular Biology	2010	169

Page 1